Alliance launches with 26 founding companies to develop a national strategy for U.S. biotechnology leadershipBOCA RATON, Fla., May 13, 2026 ...

想象一下，如果能在数字世界里完整复制一个你的器官，当疾病来袭时，先让这个“数字孪生”去试药，是不是就能完美避开药物副作用，并精准预测疗效？这听起来像是科幻电影中的情节，但在生物医学领域，这扇大门正在被缓缓推开。 数字孪生（Digital ...

今天，Unity Biotechnology 宣布获得 1.16 亿美元 B 轮融资，由亚马逊 CEO Jeff Bezos 领投，梅奥医学中心、苏格兰互惠基金 Baillie Gifford、Venrock、生命科学投资机构 ARCH Venture Capital 和药明康德等参投。公司计划利用本轮融资扩大目前正在进行中的细胞衰老研究计划，并推进公司首个临床前项目进入人体试验阶段。

Automation, AI, and screening technologies are already transforming reproductive medicine. The tools may be accurate, but ...

未来，随着体内高通量筛选技术的不断进步，结合更加丰富的多组学数据，类似MOLEA这样的多目标优化模型必将向更加复杂的给药途径（如静脉注射靶向肝外特定器官）发起冲击。这不仅将大幅压缩药物研发的试错成本和时间周期，更将重塑我们对纳米医学底层设计逻辑的认知。在通往精准医疗的道路上， 如何让科技的利刃不仅锋利，而且更懂得收敛和克制 ，这或许是该研究留给我们的最深长远的思考。

(Michael on for Roanna Ruiz), Leerink Partners: "what would constitute a clear signal as a green light to initiate Phase III in 2027?"; President, CEO & Director De Backer: "it's going to really be ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Investors were disappointed with the weak earnings posted by Puma Biotechnology, Inc. ( NASDAQ:PBYI ). Despite the ...

Bank of America Global Healthcare Conference 2026 May 12, 2026 5:20 PM EDTCompany ParticipantsSteven Harr - President, ...

Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on VIR. Vir Biotechnology, ...

Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent ...